FIELD: medicine.
SUBSTANCE: invention concerns medicine, particularly therapy and neurology and selection of treatment tactics for chronic cerebral ischemia cases. It involves determination of electrophoretic mobility of erythrocytes. Its rise above 1.26±0.02 indicates preservation of adaptation reserves and suitability of administering adaptogens of herbal origin for activation of stress-realising body systems. Electrophoretic mobility fallen under 1.21±0.012 indicates depletion of body adaptation capacity and suitability of administering neuropeptides of stress-limiting effect.
EFFECT: enhanced treatment efficiency, reduced side effects due to taking individual features of adaptation process into account.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SELECTING A THERAPEUTIC APPROACH TO PATIENTS WITH MUSCULAR DYSTONIA | 2018 |
|
RU2686083C1 |
| METHOD FOR ASSESSING BODY STRESS-REACTIVITY | 2018 |
|
RU2697884C1 |
| METHOD OF PREDICTING EFFICIENCY OF TREATMENT OF PATIENTS WITH CHRONIC BRAIN ISCHEMIA AND TYPE 2 DIABETES MELLITUS WITH PHARMACOLOGIC PREPARATION MILDRONAT | 2010 |
|
RU2427367C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF PSYCHOSOMATIC AND SOMATIC DISEASES | 2017 |
|
RU2672886C1 |
| AGENT FOR NORMALIZATION OF AGGREGATIVE PROPERTIES OF PLATELETS AND ERYTHROCYTES AND MORPHODENSITOMETRIC INDICES OF ERYTHROCYTES | 2003 |
|
RU2245145C1 |
| METHOD FOR TREATING INITIAL FORMS OF CEREBROVASCULAR PATHLOGY AT THE BACKGROUND OF ARTERIAL HYPERTENSION | 2004 |
|
RU2281747C1 |
| METHOD OF INTEGRATED TREATMENT OF PATIENTS WITH DISCIRCULATORY ENCEPHALOPATHY | 2011 |
|
RU2449822C1 |
| METHOD FOR IMMUNOCORRECTION IN CASE OF CHRONIC CEREBRAL ISCHEMIA | 2016 |
|
RU2629813C1 |
| METHOD FOR TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS (OPTIONS) | 2017 |
|
RU2659674C1 |
| PREPARATION FOR TREATING DISCIRCULATORY ENCEPHALOPATHY | 2002 |
|
RU2197991C1 |
